143 related articles for article (PubMed ID: 7482301)
1. [The clinical significance of the immunological phenotype in non-Hodgkin's lymphomas].
Golenkov AK; Miterev GIu; Popov VM; Shakher AL
Ter Arkh; 1995; 67(7):30-2. PubMed ID: 7482301
[TBL] [Abstract][Full Text] [Related]
2. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.
Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS
Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943
[TBL] [Abstract][Full Text] [Related]
3. [Verification of hematological studies and immunologic phenotype of lymphoma cells in the blood by histological examination of the lymph nodes in non-Hodgkin's lymphoma of low and medium degree of malignancy].
Urasiński I; Krygier-Stojałowska A; Sochacka-Kuzko B
Acta Haematol Pol; 1989; 20(1):72-82. PubMed ID: 2618569
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry immunophenotyping (FCI) of fine needle aspirates (FNAs) of lymph nodes.
Paro MM; Siftar Z; Kardum-Skelin I; Sustercić D; Nazor A; Flegar-Mestrić Z; Jaksić B
Coll Antropol; 2010 Jun; 34(2):359-65. PubMed ID: 20698103
[TBL] [Abstract][Full Text] [Related]
6. [The clinical significance of the immunophenotyping of the tumor cells in nonleukemic hemoblastoses of a lymphatic nature].
Baĭdurin SA; Samoĭlova RS; Grigor'eva MA; Kaplanskaia IB
Ter Arkh; 1992; 64(7):43-9. PubMed ID: 1440367
[No Abstract] [Full Text] [Related]
7. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
Dzembak TM; Gurkalo VK; Gershanovich ML
Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
[TBL] [Abstract][Full Text] [Related]
10. The role of flow cytometry in the diagnosis of lymphoma: a critical analysis.
Morse EE; Yamase HT; Greenberg BR; Sporn J; Harshaw SA; Kiraly TR; Ziemba RA; Fallon MA
Ann Clin Lab Sci; 1994; 24(1):6-11. PubMed ID: 8147568
[TBL] [Abstract][Full Text] [Related]
11. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.
Baird S
Crit Rev Clin Lab Sci; 1993; 30(1):1-28. PubMed ID: 8489735
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of composite nodal B-cell lymphoma and subsequent Hodgkin's disease by flow cytometry and immunohistochemistry. Case report and review of the literature.
Dunphy CH; Craver JL; Emerson WA
Arch Pathol Lab Med; 1997 Jun; 121(6):637-40. PubMed ID: 9199634
[TBL] [Abstract][Full Text] [Related]
14. Circulating buttock cells in non-Hodgkin's lymphoma.
Verbunt RJ; den Ottolander GJ; Kluin PM; Brederoo P; Kluin-Nelemans HC
Leukemia; 1989 Aug; 3(8):578-84. PubMed ID: 2787452
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
16. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
Pituch-Noworolska A; Miezyński W
Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
[TBL] [Abstract][Full Text] [Related]
17. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
18. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders.
Tbakhi A; Edinger M; Myles J; Pohlman B; Tubbs RR
Cytometry; 1996 Oct; 25(2):113-24. PubMed ID: 8891441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
